Last Updated on October 17, 2024 by The Health Master
USFDA has approved ZIMHI (naloxone hydrochloride) injection as an additional option to treat opioid overdose.
ZIMHI is administered using a single-dose, prefilled syringe that delivers 5 milligrams (mg) of naloxone hydrochloride solution through intramuscular (in the muscle) or subcutaneous (under the skin) injection.
USFDA has previously approved injectable naloxone hydrochloride products in 0.4 mg and 2 mg doses under the trade name, NARCAN.
Disease or Condition:
Naloxone is a medicine that can be administered by individuals with or without medical training to help reduce opioid overdose deaths.
If naloxone is administered quickly, it can counter the opioid overdose effects, usually within minutes. A 5 mg/0.5 mL prefilled syringe of naloxone provides an additional option in the treatment of opioid overdoses.
Opioids are a class of drugs that include prescription medications such as oxycodone, hydrocodone, and morphine, as well as the illegal drug heroin.
Opioid-related overdose deaths—driven partly by prescription drug overdoses—are one of the leading causes of death in the United States.
When someone overdoses on an opioid, it can be difficult to awaken the person, and breathing may become shallow or stop – leading to death if there is no medical intervention.
Safety Information:
Use of naloxone in patients who are opioid-dependent may result in opioid withdrawal, characterized by rapid onset of severe body aches, vomiting, diarrhea, increased heart rate (tachycardia), fever, runny nose, sneezing, goose bumps (piloerection), sweating, yawning, nausea, nervousness, restlessness or irritability, shivering or trembling, abdominal cramps, weakness and increased blood pressure.
USFDA gives approval for Eye Injection to teat vision loss
USFDA approval for J&J and Moderna C-19 booster dose
Dr Reddy’s Lab gets USFDA nod for Lenalidomide capsule
USFDA gives tentative nod to Gland Pharma for generic muscle relaxant drug
USFDA gives nod to Drug to treat Rare Autoimmune Disease
USFDA gives tentative nod to Lupin for generic Brexpiprazole tablets
Govt extends validity of licences of Distilleries to mfr Hand Sanitizer
NPPA sets up PMRUs in 19 states and Union Territories
APIs Price hike impacts Indian Pharma Industry badly
USFDA gives approval for Eye Injection to teat vision loss
EU Regulator starts real-time review of anti viral drug Molnupiravir
Designing a better bottle for Eye Drops is need of the…
Ministry: Decriminalising possession of small amount of drugs for personal use
Bharat Bitoech is waiting for DCGI nod for children’s C-19 Vaccine
Procedure to obtain license for manufacturing of Homoeopathic Medicines
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
